Insider Transactions in Q4 2022 at Aerovate Therapeutics, Inc. (AVTE)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 10
2022
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
4,954
-85.57%
|
$84,218
$17.01 P/Share
|
|
Oct 10
2022
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
4,954
+50.0%
|
$9,908
$2.14 P/Share
|
|
Oct 07
2022
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
10,520
-91.65%
|
$168,320
$16.17 P/Share
|
|
Oct 07
2022
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
10,520
+50.0%
|
$21,040
$2.14 P/Share
|
|
Oct 06
2022
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
13,040
-78.05%
|
$208,640
$16.5 P/Share
|
|
Oct 06
2022
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
13,040
+47.45%
|
$13,040
$1.94 P/Share
|
|
Oct 05
2022
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,250
-31.98%
|
$33,750
$15.97 P/Share
|
|
Oct 05
2022
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+25.83%
|
$2,250
$1.94 P/Share
|